nodes	percent_of_prediction	percent_of_DWPC	metapath
Metronidazole—CYP3A4—Thiotepa—sarcoma	0.168	0.351	CbGbCtD
Metronidazole—CYP2C8—Etoposide—sarcoma	0.112	0.235	CbGbCtD
Metronidazole—CYP3A4—Mitoxantrone—sarcoma	0.0721	0.151	CbGbCtD
Metronidazole—CYP3A4—Vincristine—sarcoma	0.0496	0.104	CbGbCtD
Metronidazole—CYP3A4—Etoposide—sarcoma	0.0455	0.0951	CbGbCtD
Metronidazole—CYP3A4—Doxorubicin—sarcoma	0.031	0.0649	CbGbCtD
Metronidazole—Pruritus—Thiotepa—sarcoma	0.000559	0.00107	CcSEcCtD
Metronidazole—Gastrointestinal pain—Mitoxantrone—sarcoma	0.000558	0.00107	CcSEcCtD
Metronidazole—Thrombocytopenia—Etoposide—sarcoma	0.000556	0.00106	CcSEcCtD
Metronidazole—Eosinophilia—Epirubicin—sarcoma	0.000554	0.00106	CcSEcCtD
Metronidazole—Abdominal pain—Vincristine—sarcoma	0.000554	0.00106	CcSEcCtD
Metronidazole—Body temperature increased—Vincristine—sarcoma	0.000554	0.00106	CcSEcCtD
Metronidazole—Liver function test abnormal—Doxorubicin—sarcoma	0.000553	0.00106	CcSEcCtD
Metronidazole—Skin disorder—Etoposide—sarcoma	0.000551	0.00106	CcSEcCtD
Metronidazole—Dry skin—Doxorubicin—sarcoma	0.000549	0.00105	CcSEcCtD
Metronidazole—Hyperhidrosis—Etoposide—sarcoma	0.000549	0.00105	CcSEcCtD
Metronidazole—Pancreatitis—Epirubicin—sarcoma	0.000548	0.00105	CcSEcCtD
Metronidazole—Abdominal pain upper—Doxorubicin—sarcoma	0.000547	0.00105	CcSEcCtD
Metronidazole—Urticaria—Mitoxantrone—sarcoma	0.000542	0.00104	CcSEcCtD
Metronidazole—Breast disorder—Doxorubicin—sarcoma	0.000541	0.00104	CcSEcCtD
Metronidazole—Anorexia—Etoposide—sarcoma	0.000541	0.00104	CcSEcCtD
Metronidazole—Diarrhoea—Thiotepa—sarcoma	0.000541	0.00104	CcSEcCtD
Metronidazole—Abdominal pain—Mitoxantrone—sarcoma	0.000539	0.00103	CcSEcCtD
Metronidazole—Body temperature increased—Mitoxantrone—sarcoma	0.000539	0.00103	CcSEcCtD
Metronidazole—Toxic epidermal necrolysis—Doxorubicin—sarcoma	0.000539	0.00103	CcSEcCtD
Metronidazole—Bronchitis—Epirubicin—sarcoma	0.000538	0.00103	CcSEcCtD
Metronidazole—Diarrhoea—Dactinomycin—sarcoma	0.000537	0.00103	CcSEcCtD
Metronidazole—Nasopharyngitis—Doxorubicin—sarcoma	0.000536	0.00103	CcSEcCtD
Metronidazole—Pancytopenia—Epirubicin—sarcoma	0.000531	0.00102	CcSEcCtD
Metronidazole—Dysuria—Epirubicin—sarcoma	0.000523	0.001	CcSEcCtD
Metronidazole—Neutropenia—Epirubicin—sarcoma	0.000523	0.001	CcSEcCtD
Metronidazole—Dizziness—Thiotepa—sarcoma	0.000522	0.001	CcSEcCtD
Metronidazole—Abdominal distension—Doxorubicin—sarcoma	0.000521	0.000999	CcSEcCtD
Metronidazole—Upper respiratory tract infection—Epirubicin—sarcoma	0.00052	0.000996	CcSEcCtD
Metronidazole—Asthma—Doxorubicin—sarcoma	0.000518	0.000992	CcSEcCtD
Metronidazole—Influenza—Doxorubicin—sarcoma	0.000518	0.000992	CcSEcCtD
Metronidazole—Pollakiuria—Epirubicin—sarcoma	0.000517	0.00099	CcSEcCtD
Metronidazole—Hypersensitivity—Vincristine—sarcoma	0.000516	0.000989	CcSEcCtD
Metronidazole—Eosinophilia—Doxorubicin—sarcoma	0.000513	0.000982	CcSEcCtD
Metronidazole—Photosensitivity reaction—Epirubicin—sarcoma	0.000511	0.000978	CcSEcCtD
Metronidazole—Paraesthesia—Etoposide—sarcoma	0.00051	0.000976	CcSEcCtD
Metronidazole—Pancreatitis—Doxorubicin—sarcoma	0.000508	0.000972	CcSEcCtD
Metronidazole—Somnolence—Etoposide—sarcoma	0.000505	0.000967	CcSEcCtD
Metronidazole—Hypersensitivity—Mitoxantrone—sarcoma	0.000503	0.000963	CcSEcCtD
Metronidazole—Asthenia—Vincristine—sarcoma	0.000503	0.000963	CcSEcCtD
Metronidazole—Vomiting—Thiotepa—sarcoma	0.000502	0.000963	CcSEcCtD
Metronidazole—Infestation—Epirubicin—sarcoma	0.000499	0.000956	CcSEcCtD
Metronidazole—Drowsiness—Epirubicin—sarcoma	0.000499	0.000956	CcSEcCtD
Metronidazole—Infestation NOS—Epirubicin—sarcoma	0.000499	0.000956	CcSEcCtD
Metronidazole—Vomiting—Dactinomycin—sarcoma	0.000499	0.000955	CcSEcCtD
Metronidazole—Rash—Thiotepa—sarcoma	0.000498	0.000955	CcSEcCtD
Metronidazole—Bronchitis—Doxorubicin—sarcoma	0.000498	0.000954	CcSEcCtD
Metronidazole—Dermatitis—Thiotepa—sarcoma	0.000498	0.000954	CcSEcCtD
Metronidazole—Headache—Thiotepa—sarcoma	0.000495	0.000948	CcSEcCtD
Metronidazole—Stevens-Johnson syndrome—Epirubicin—sarcoma	0.000495	0.000948	CcSEcCtD
Metronidazole—Rash—Dactinomycin—sarcoma	0.000494	0.000947	CcSEcCtD
Metronidazole—Decreased appetite—Etoposide—sarcoma	0.000493	0.000945	CcSEcCtD
Metronidazole—Pancytopenia—Doxorubicin—sarcoma	0.000492	0.000942	CcSEcCtD
Metronidazole—Gastrointestinal disorder—Etoposide—sarcoma	0.00049	0.000939	CcSEcCtD
Metronidazole—Asthenia—Mitoxantrone—sarcoma	0.00049	0.000938	CcSEcCtD
Metronidazole—Fatigue—Etoposide—sarcoma	0.000489	0.000938	CcSEcCtD
Metronidazole—Neuropathy peripheral—Epirubicin—sarcoma	0.000489	0.000937	CcSEcCtD
Metronidazole—Jaundice—Epirubicin—sarcoma	0.000486	0.000932	CcSEcCtD
Metronidazole—Stomatitis—Epirubicin—sarcoma	0.000486	0.000932	CcSEcCtD
Metronidazole—Pain—Etoposide—sarcoma	0.000485	0.00093	CcSEcCtD
Metronidazole—Constipation—Etoposide—sarcoma	0.000485	0.00093	CcSEcCtD
Metronidazole—Conjunctivitis—Epirubicin—sarcoma	0.000485	0.000929	CcSEcCtD
Metronidazole—Urinary tract infection—Epirubicin—sarcoma	0.000485	0.000929	CcSEcCtD
Metronidazole—Dysuria—Doxorubicin—sarcoma	0.000484	0.000927	CcSEcCtD
Metronidazole—Neutropenia—Doxorubicin—sarcoma	0.000484	0.000927	CcSEcCtD
Metronidazole—Upper respiratory tract infection—Doxorubicin—sarcoma	0.000481	0.000922	CcSEcCtD
Metronidazole—Diarrhoea—Vincristine—sarcoma	0.000479	0.000919	CcSEcCtD
Metronidazole—Sweating—Epirubicin—sarcoma	0.000478	0.000916	CcSEcCtD
Metronidazole—Pollakiuria—Doxorubicin—sarcoma	0.000478	0.000916	CcSEcCtD
Metronidazole—Photosensitivity reaction—Doxorubicin—sarcoma	0.000472	0.000905	CcSEcCtD
Metronidazole—Hepatobiliary disease—Epirubicin—sarcoma	0.000472	0.000904	CcSEcCtD
Metronidazole—Nausea—Thiotepa—sarcoma	0.000469	0.000899	CcSEcCtD
Metronidazole—Sinusitis—Epirubicin—sarcoma	0.000468	0.000897	CcSEcCtD
Metronidazole—Feeling abnormal—Etoposide—sarcoma	0.000468	0.000896	CcSEcCtD
Metronidazole—Diarrhoea—Mitoxantrone—sarcoma	0.000467	0.000895	CcSEcCtD
Metronidazole—Nausea—Dactinomycin—sarcoma	0.000466	0.000892	CcSEcCtD
Metronidazole—Agranulocytosis—Epirubicin—sarcoma	0.000465	0.000892	CcSEcCtD
Metronidazole—Gastrointestinal pain—Etoposide—sarcoma	0.000464	0.000889	CcSEcCtD
Metronidazole—Dizziness—Vincristine—sarcoma	0.000463	0.000888	CcSEcCtD
Metronidazole—Drowsiness—Doxorubicin—sarcoma	0.000462	0.000884	CcSEcCtD
Metronidazole—Infestation NOS—Doxorubicin—sarcoma	0.000462	0.000884	CcSEcCtD
Metronidazole—Infestation—Doxorubicin—sarcoma	0.000462	0.000884	CcSEcCtD
Metronidazole—Stevens-Johnson syndrome—Doxorubicin—sarcoma	0.000458	0.000877	CcSEcCtD
Metronidazole—Neuropathy peripheral—Doxorubicin—sarcoma	0.000452	0.000867	CcSEcCtD
Metronidazole—Urticaria—Etoposide—sarcoma	0.000451	0.000864	CcSEcCtD
Metronidazole—Jaundice—Doxorubicin—sarcoma	0.00045	0.000862	CcSEcCtD
Metronidazole—Stomatitis—Doxorubicin—sarcoma	0.00045	0.000862	CcSEcCtD
Metronidazole—Rhinitis—Epirubicin—sarcoma	0.000449	0.00086	CcSEcCtD
Metronidazole—Body temperature increased—Etoposide—sarcoma	0.000449	0.00086	CcSEcCtD
Metronidazole—Abdominal pain—Etoposide—sarcoma	0.000449	0.00086	CcSEcCtD
Metronidazole—Conjunctivitis—Doxorubicin—sarcoma	0.000449	0.00086	CcSEcCtD
Metronidazole—Urinary tract infection—Doxorubicin—sarcoma	0.000449	0.00086	CcSEcCtD
Metronidazole—Hepatitis—Epirubicin—sarcoma	0.000448	0.000858	CcSEcCtD
Metronidazole—Hypoaesthesia—Epirubicin—sarcoma	0.000446	0.000854	CcSEcCtD
Metronidazole—Vomiting—Vincristine—sarcoma	0.000445	0.000854	CcSEcCtD
Metronidazole—Pharyngitis—Epirubicin—sarcoma	0.000444	0.000852	CcSEcCtD
Metronidazole—Sweating—Doxorubicin—sarcoma	0.000442	0.000848	CcSEcCtD
Metronidazole—Rash—Vincristine—sarcoma	0.000442	0.000846	CcSEcCtD
Metronidazole—Dermatitis—Vincristine—sarcoma	0.000441	0.000846	CcSEcCtD
Metronidazole—Connective tissue disorder—Epirubicin—sarcoma	0.00044	0.000843	CcSEcCtD
Metronidazole—Headache—Vincristine—sarcoma	0.000439	0.000841	CcSEcCtD
Metronidazole—Hepatobiliary disease—Doxorubicin—sarcoma	0.000437	0.000836	CcSEcCtD
Metronidazole—Vomiting—Mitoxantrone—sarcoma	0.000434	0.000831	CcSEcCtD
Metronidazole—Sinusitis—Doxorubicin—sarcoma	0.000433	0.00083	CcSEcCtD
Metronidazole—Visual impairment—Epirubicin—sarcoma	0.000432	0.000827	CcSEcCtD
Metronidazole—Agranulocytosis—Doxorubicin—sarcoma	0.000431	0.000825	CcSEcCtD
Metronidazole—Rash—Mitoxantrone—sarcoma	0.00043	0.000824	CcSEcCtD
Metronidazole—Dermatitis—Mitoxantrone—sarcoma	0.00043	0.000824	CcSEcCtD
Metronidazole—Headache—Mitoxantrone—sarcoma	0.000427	0.000819	CcSEcCtD
Metronidazole—Erythema multiforme—Epirubicin—sarcoma	0.000423	0.000811	CcSEcCtD
Metronidazole—Eye disorder—Epirubicin—sarcoma	0.000418	0.000802	CcSEcCtD
Metronidazole—Hypersensitivity—Etoposide—sarcoma	0.000418	0.000801	CcSEcCtD
Metronidazole—Tinnitus—Epirubicin—sarcoma	0.000418	0.0008	CcSEcCtD
Metronidazole—Nausea—Vincristine—sarcoma	0.000416	0.000797	CcSEcCtD
Metronidazole—Cardiac disorder—Epirubicin—sarcoma	0.000416	0.000796	CcSEcCtD
Metronidazole—Flushing—Epirubicin—sarcoma	0.000416	0.000796	CcSEcCtD
Metronidazole—Rhinitis—Doxorubicin—sarcoma	0.000415	0.000796	CcSEcCtD
Metronidazole—Hepatitis—Doxorubicin—sarcoma	0.000414	0.000794	CcSEcCtD
Metronidazole—Hypoaesthesia—Doxorubicin—sarcoma	0.000412	0.00079	CcSEcCtD
Metronidazole—Pharyngitis—Doxorubicin—sarcoma	0.000411	0.000788	CcSEcCtD
Metronidazole—Asthenia—Etoposide—sarcoma	0.000407	0.00078	CcSEcCtD
Metronidazole—Connective tissue disorder—Doxorubicin—sarcoma	0.000407	0.00078	CcSEcCtD
Metronidazole—Angiopathy—Epirubicin—sarcoma	0.000406	0.000778	CcSEcCtD
Metronidazole—Nausea—Mitoxantrone—sarcoma	0.000405	0.000777	CcSEcCtD
Metronidazole—Immune system disorder—Epirubicin—sarcoma	0.000404	0.000775	CcSEcCtD
Metronidazole—Mediastinal disorder—Epirubicin—sarcoma	0.000404	0.000773	CcSEcCtD
Metronidazole—Pruritus—Etoposide—sarcoma	0.000402	0.000769	CcSEcCtD
Metronidazole—Visual impairment—Doxorubicin—sarcoma	0.000399	0.000765	CcSEcCtD
Metronidazole—Mental disorder—Epirubicin—sarcoma	0.000392	0.000752	CcSEcCtD
Metronidazole—Erythema multiforme—Doxorubicin—sarcoma	0.000392	0.000751	CcSEcCtD
Metronidazole—Erythema—Epirubicin—sarcoma	0.00039	0.000747	CcSEcCtD
Metronidazole—Diarrhoea—Etoposide—sarcoma	0.000388	0.000744	CcSEcCtD
Metronidazole—Eye disorder—Doxorubicin—sarcoma	0.000387	0.000742	CcSEcCtD
Metronidazole—Tinnitus—Doxorubicin—sarcoma	0.000386	0.00074	CcSEcCtD
Metronidazole—Flushing—Doxorubicin—sarcoma	0.000385	0.000737	CcSEcCtD
Metronidazole—Cardiac disorder—Doxorubicin—sarcoma	0.000385	0.000737	CcSEcCtD
Metronidazole—Flatulence—Epirubicin—sarcoma	0.000384	0.000736	CcSEcCtD
Metronidazole—Dysgeusia—Epirubicin—sarcoma	0.000382	0.000731	CcSEcCtD
Metronidazole—Back pain—Epirubicin—sarcoma	0.000377	0.000722	CcSEcCtD
Metronidazole—Angiopathy—Doxorubicin—sarcoma	0.000376	0.00072	CcSEcCtD
Metronidazole—Dizziness—Etoposide—sarcoma	0.000375	0.000719	CcSEcCtD
Metronidazole—Muscle spasms—Epirubicin—sarcoma	0.000375	0.000718	CcSEcCtD
Metronidazole—Immune system disorder—Doxorubicin—sarcoma	0.000374	0.000717	CcSEcCtD
Metronidazole—Mediastinal disorder—Doxorubicin—sarcoma	0.000373	0.000716	CcSEcCtD
Metronidazole—Vision blurred—Epirubicin—sarcoma	0.000367	0.000704	CcSEcCtD
Metronidazole—Mental disorder—Doxorubicin—sarcoma	0.000363	0.000696	CcSEcCtD
Metronidazole—Vomiting—Etoposide—sarcoma	0.000361	0.000691	CcSEcCtD
Metronidazole—Erythema—Doxorubicin—sarcoma	0.000361	0.000691	CcSEcCtD
Metronidazole—Rash—Etoposide—sarcoma	0.000358	0.000686	CcSEcCtD
Metronidazole—Dermatitis—Etoposide—sarcoma	0.000358	0.000685	CcSEcCtD
Metronidazole—Headache—Etoposide—sarcoma	0.000356	0.000681	CcSEcCtD
Metronidazole—Flatulence—Doxorubicin—sarcoma	0.000355	0.000681	CcSEcCtD
Metronidazole—Dysgeusia—Doxorubicin—sarcoma	0.000353	0.000677	CcSEcCtD
Metronidazole—Malaise—Epirubicin—sarcoma	0.000352	0.000674	CcSEcCtD
Metronidazole—Vertigo—Epirubicin—sarcoma	0.00035	0.000671	CcSEcCtD
Metronidazole—Syncope—Epirubicin—sarcoma	0.00035	0.00067	CcSEcCtD
Metronidazole—Leukopenia—Epirubicin—sarcoma	0.000349	0.000669	CcSEcCtD
Metronidazole—Back pain—Doxorubicin—sarcoma	0.000349	0.000669	CcSEcCtD
Metronidazole—Muscle spasms—Doxorubicin—sarcoma	0.000347	0.000664	CcSEcCtD
Metronidazole—Palpitations—Epirubicin—sarcoma	0.000344	0.00066	CcSEcCtD
Metronidazole—Loss of consciousness—Epirubicin—sarcoma	0.000343	0.000656	CcSEcCtD
Metronidazole—Vision blurred—Doxorubicin—sarcoma	0.00034	0.000651	CcSEcCtD
Metronidazole—Convulsion—Epirubicin—sarcoma	0.000338	0.000647	CcSEcCtD
Metronidazole—Nausea—Etoposide—sarcoma	0.000337	0.000646	CcSEcCtD
Metronidazole—Hypertension—Epirubicin—sarcoma	0.000337	0.000645	CcSEcCtD
Metronidazole—Chest pain—Epirubicin—sarcoma	0.000332	0.000636	CcSEcCtD
Metronidazole—Arthralgia—Epirubicin—sarcoma	0.000332	0.000636	CcSEcCtD
Metronidazole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.00033	0.000632	CcSEcCtD
Metronidazole—Malaise—Doxorubicin—sarcoma	0.000325	0.000623	CcSEcCtD
Metronidazole—Dry mouth—Epirubicin—sarcoma	0.000325	0.000622	CcSEcCtD
Metronidazole—Vertigo—Doxorubicin—sarcoma	0.000324	0.000621	CcSEcCtD
Metronidazole—Syncope—Doxorubicin—sarcoma	0.000323	0.00062	CcSEcCtD
Metronidazole—Leukopenia—Doxorubicin—sarcoma	0.000323	0.000619	CcSEcCtD
Metronidazole—Confusional state—Epirubicin—sarcoma	0.000321	0.000615	CcSEcCtD
Metronidazole—Palpitations—Doxorubicin—sarcoma	0.000319	0.000611	CcSEcCtD
Metronidazole—Anaphylactic shock—Epirubicin—sarcoma	0.000318	0.00061	CcSEcCtD
Metronidazole—Oedema—Epirubicin—sarcoma	0.000318	0.00061	CcSEcCtD
Metronidazole—Loss of consciousness—Doxorubicin—sarcoma	0.000317	0.000607	CcSEcCtD
Metronidazole—Infection—Epirubicin—sarcoma	0.000316	0.000606	CcSEcCtD
Metronidazole—Shock—Epirubicin—sarcoma	0.000313	0.0006	CcSEcCtD
Metronidazole—Convulsion—Doxorubicin—sarcoma	0.000313	0.000599	CcSEcCtD
Metronidazole—Nervous system disorder—Epirubicin—sarcoma	0.000312	0.000598	CcSEcCtD
Metronidazole—Thrombocytopenia—Epirubicin—sarcoma	0.000311	0.000597	CcSEcCtD
Metronidazole—Hypertension—Doxorubicin—sarcoma	0.000311	0.000597	CcSEcCtD
Metronidazole—Skin disorder—Epirubicin—sarcoma	0.000309	0.000592	CcSEcCtD
Metronidazole—Hyperhidrosis—Epirubicin—sarcoma	0.000308	0.000589	CcSEcCtD
Metronidazole—Chest pain—Doxorubicin—sarcoma	0.000307	0.000588	CcSEcCtD
Metronidazole—Arthralgia—Doxorubicin—sarcoma	0.000307	0.000588	CcSEcCtD
Metronidazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000305	0.000584	CcSEcCtD
Metronidazole—Anorexia—Epirubicin—sarcoma	0.000303	0.000581	CcSEcCtD
Metronidazole—Dry mouth—Doxorubicin—sarcoma	0.0003	0.000575	CcSEcCtD
Metronidazole—Confusional state—Doxorubicin—sarcoma	0.000297	0.000569	CcSEcCtD
Metronidazole—Oedema—Doxorubicin—sarcoma	0.000294	0.000564	CcSEcCtD
Metronidazole—Anaphylactic shock—Doxorubicin—sarcoma	0.000294	0.000564	CcSEcCtD
Metronidazole—Infection—Doxorubicin—sarcoma	0.000292	0.00056	CcSEcCtD
Metronidazole—Musculoskeletal discomfort—Epirubicin—sarcoma	0.00029	0.000555	CcSEcCtD
Metronidazole—Shock—Doxorubicin—sarcoma	0.00029	0.000555	CcSEcCtD
Metronidazole—Nervous system disorder—Doxorubicin—sarcoma	0.000289	0.000553	CcSEcCtD
Metronidazole—Thrombocytopenia—Doxorubicin—sarcoma	0.000288	0.000552	CcSEcCtD
Metronidazole—Insomnia—Epirubicin—sarcoma	0.000288	0.000551	CcSEcCtD
Metronidazole—Skin disorder—Doxorubicin—sarcoma	0.000286	0.000548	CcSEcCtD
Metronidazole—Paraesthesia—Epirubicin—sarcoma	0.000286	0.000547	CcSEcCtD
Metronidazole—Hyperhidrosis—Doxorubicin—sarcoma	0.000285	0.000545	CcSEcCtD
Metronidazole—Somnolence—Epirubicin—sarcoma	0.000283	0.000542	CcSEcCtD
Metronidazole—Anorexia—Doxorubicin—sarcoma	0.000281	0.000538	CcSEcCtD
Metronidazole—Dyspepsia—Epirubicin—sarcoma	0.00028	0.000537	CcSEcCtD
Metronidazole—Decreased appetite—Epirubicin—sarcoma	0.000277	0.00053	CcSEcCtD
Metronidazole—Gastrointestinal disorder—Epirubicin—sarcoma	0.000275	0.000526	CcSEcCtD
Metronidazole—Fatigue—Epirubicin—sarcoma	0.000274	0.000526	CcSEcCtD
Metronidazole—Pain—Epirubicin—sarcoma	0.000272	0.000521	CcSEcCtD
Metronidazole—Constipation—Epirubicin—sarcoma	0.000272	0.000521	CcSEcCtD
Metronidazole—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000268	0.000514	CcSEcCtD
Metronidazole—Insomnia—Doxorubicin—sarcoma	0.000266	0.00051	CcSEcCtD
Metronidazole—Paraesthesia—Doxorubicin—sarcoma	0.000264	0.000506	CcSEcCtD
Metronidazole—Feeling abnormal—Epirubicin—sarcoma	0.000262	0.000502	CcSEcCtD
Metronidazole—Somnolence—Doxorubicin—sarcoma	0.000262	0.000501	CcSEcCtD
Metronidazole—Gastrointestinal pain—Epirubicin—sarcoma	0.00026	0.000498	CcSEcCtD
Metronidazole—Dyspepsia—Doxorubicin—sarcoma	0.000259	0.000496	CcSEcCtD
Metronidazole—Decreased appetite—Doxorubicin—sarcoma	0.000256	0.00049	CcSEcCtD
Metronidazole—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000254	0.000487	CcSEcCtD
Metronidazole—Fatigue—Doxorubicin—sarcoma	0.000254	0.000486	CcSEcCtD
Metronidazole—Urticaria—Epirubicin—sarcoma	0.000253	0.000484	CcSEcCtD
Metronidazole—Constipation—Doxorubicin—sarcoma	0.000252	0.000482	CcSEcCtD
Metronidazole—Pain—Doxorubicin—sarcoma	0.000252	0.000482	CcSEcCtD
Metronidazole—Abdominal pain—Epirubicin—sarcoma	0.000251	0.000482	CcSEcCtD
Metronidazole—Body temperature increased—Epirubicin—sarcoma	0.000251	0.000482	CcSEcCtD
Metronidazole—Feeling abnormal—Doxorubicin—sarcoma	0.000243	0.000465	CcSEcCtD
Metronidazole—Gastrointestinal pain—Doxorubicin—sarcoma	0.000241	0.000461	CcSEcCtD
Metronidazole—Hypersensitivity—Epirubicin—sarcoma	0.000234	0.000449	CcSEcCtD
Metronidazole—Urticaria—Doxorubicin—sarcoma	0.000234	0.000448	CcSEcCtD
Metronidazole—Body temperature increased—Doxorubicin—sarcoma	0.000233	0.000446	CcSEcCtD
Metronidazole—Abdominal pain—Doxorubicin—sarcoma	0.000233	0.000446	CcSEcCtD
Metronidazole—Asthenia—Epirubicin—sarcoma	0.000228	0.000437	CcSEcCtD
Metronidazole—Pruritus—Epirubicin—sarcoma	0.000225	0.000431	CcSEcCtD
Metronidazole—Diarrhoea—Epirubicin—sarcoma	0.000218	0.000417	CcSEcCtD
Metronidazole—Hypersensitivity—Doxorubicin—sarcoma	0.000217	0.000416	CcSEcCtD
Metronidazole—Asthenia—Doxorubicin—sarcoma	0.000211	0.000405	CcSEcCtD
Metronidazole—Dizziness—Epirubicin—sarcoma	0.00021	0.000403	CcSEcCtD
Metronidazole—Pruritus—Doxorubicin—sarcoma	0.000208	0.000399	CcSEcCtD
Metronidazole—Vomiting—Epirubicin—sarcoma	0.000202	0.000388	CcSEcCtD
Metronidazole—Diarrhoea—Doxorubicin—sarcoma	0.000201	0.000386	CcSEcCtD
Metronidazole—Rash—Epirubicin—sarcoma	0.000201	0.000384	CcSEcCtD
Metronidazole—Dermatitis—Epirubicin—sarcoma	0.0002	0.000384	CcSEcCtD
Metronidazole—Headache—Epirubicin—sarcoma	0.000199	0.000382	CcSEcCtD
Metronidazole—Dizziness—Doxorubicin—sarcoma	0.000195	0.000373	CcSEcCtD
Metronidazole—Nausea—Epirubicin—sarcoma	0.000189	0.000362	CcSEcCtD
Metronidazole—Vomiting—Doxorubicin—sarcoma	0.000187	0.000359	CcSEcCtD
Metronidazole—Rash—Doxorubicin—sarcoma	0.000186	0.000356	CcSEcCtD
Metronidazole—Dermatitis—Doxorubicin—sarcoma	0.000185	0.000355	CcSEcCtD
Metronidazole—Headache—Doxorubicin—sarcoma	0.000184	0.000353	CcSEcCtD
Metronidazole—Nausea—Doxorubicin—sarcoma	0.000175	0.000335	CcSEcCtD
